• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Rebiotix

Ferring Pharma acquires Rebiotix and its microbiome therapy platform

April 5, 2018 By Sarah Faulkner

Ferring Pharmaceuticals inked a deal to acquire Rebiotix and its platform of living drugs for an undisclosed amount, the companies announced today. The Roseville, Minn.-based company is developing a microbiome-based therapy to prevent recurrent Clostridium difficile infection. Its Microbiota Restoration Therapy, which is delivered via enema or a lyophilized, non-frozen oral capsule, is designed to supply a […]

Filed Under: Drug-Device Combinations, Mergers & Acquisitions, Pharmaceutical Tagged With: ferringpharmaceuticals, Rebiotix

Rebiotix develops tool to measure rehabilitation of microbiome

February 12, 2018 By Sarah Faulkner

Rebiotix today unveiled its Microbiome Health Index – a tool it created to establish a standard metric that can be used to quantify how effective a microbiome-based therapy is at rehabilitating the human microbiome. The index, which was developed in partnership with data analytics firm BioRankings, combines four bacterial classes into a unidimensional expression of […]

Filed Under: Big Data, Clinical Trials, Pharmaceutical Tagged With: Rebiotix

Rebiotix raises $8.5m for microbiome therapy

September 6, 2017 By Sarah Faulkner

Rebiotix has raised $8.5 million in a $10 million offering, according to a regulatory document that the company filed yesterday with the SEC. The offering, which consists of debt and convertible promissory notes, has garnered participation from 29 investors thus far, the company reported. Rebiotix said it is accepting minimum investments of $25,000 and that it doesn’t expect […]

Filed Under: Funding Roundup, Pharmaceutical Tagged With: Rebiotix

Rebiotix launches late-stage superbug trial for microbiome-based drug

August 8, 2017 By Sarah Faulkner

Rebiotix isn’t a traditional drugmaker. Its products are alive. The 32-person company, based in Roseville, Minn., is developing a microbiome-based therapy to prevent recurrent Clostridium difficile infection. Its Microbiota Restoration Therapy, which is delivered via enema or a lyophilized, non-frozen oral capsule, is designed to supply a patient’s intestinal tract with an array of healthy, human-derived microbes. Get […]

Filed Under: Clinical Trials, Hospital Care, Pharmaceutical, Regulatory/Compliance Tagged With: Rebiotix

13 more women leaders in medtech

March 10, 2017 By Danielle Kirsh

The medtech industry is increasingly gaining women leaders. Johnson & Johnson and Medtronic have a handful of women in positions of power, which is a step forward for women considering that only 4% of healthcare CEOs are women. Keeping with the theme of March’s Women’s History Month, here are 13 more women leaders in medtech that we […]

Filed Under: Biotech, Cardiovascular Tagged With: 3m, AUM Cardiovascular, Ethicon, Johnson and Johnson, MedTech, Medtronic, MyndBlue, Rebiotix, rotationmedical

A medtech veteran takes on C. diff from the gut

November 19, 2015 By Brian Johnson

Most people don’t think much about Clostridium difficile, or C. diff., until it impacts their family. That was the case for Rebiotix CEO Lee Jones, who had never heard of the disease until her mother fell ill with it several years ago. Lee says she quickly learned how dangerous the disease really is – it’s responsible for more than 29,000 […]

Filed Under: Biotech, Device Talks Podcasts Tagged With: CooperSurgical, Inlet Medical, Medtronic, Rebiotix

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS